---
title: "TD Cowen 维持对 Soleno Therapeutics（SLNO）的买入评级"
description: "Van Buren 涉及医疗保健行业，专注于 Soleno Therapeutics、Regeneron 和 Gilead Sciences 等股票。根据 TipRanks 的数据，Van Buren 的平均回报率为 3.9%，推荐股票的成功率为 48.86%。市场普遍认为，分析师对 Soleno Therapeutics 的评级为强烈买入，平均目标价为 119.30 美元，较当前水平有 101."
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/260046030.md"
published_at: "2025-10-06T11:36:02.000Z"
---

# TD Cowen 维持对 Soleno Therapeutics（SLNO）的买入评级

> Van Buren 涉及医疗保健行业，专注于 Soleno Therapeutics、Regeneron 和 Gilead Sciences 等股票。根据 TipRanks 的数据，Van Buren 的平均回报率为 3.9%，推荐股票的成功率为 48.86%。市场普遍认为，分析师对 Soleno Therapeutics 的评级为强烈买入，平均目标价为 119.30 美元，较当前水平有 101.49% 的上涨空间。在 10 月 3 日发布的一份报告中，Piper Sandler 也对该股票维持了买入评级，目标价为 145.00 美元

Van Buren 涉及医疗保健行业，专注于 Soleno Therapeutics、Regeneron 和 Gilead Sciences 等股票。根据 TipRanks 的数据，Van Buren 推荐股票的平均回报率为 3.9%，成功率为 48.86%。

市场普遍认为，分析师对 Soleno Therapeutics 的评级为强烈买入，平均目标价为 119.30 美元，较当前水平有 101.49% 的上涨空间。在 10 月 3 日发布的一份报告中，Piper Sandler 也维持了该股票的买入评级，目标价为 145.00 美元。

### Related Stocks

- [SLNO.US - Soleno治疗](https://longbridge.com/zh-CN/quote/SLNO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Stifel Nicolaus Remains a Buy on Soleno Therapeutics (SLNO) | According to TipRanks, Condulis is a 2-star analyst with an average return of 5.6% and a 61.54% success rate. Condulis c | [Link](https://longbridge.com/zh-CN/news/258743068.md) |
| LifeSci Capital Sticks to Their Buy Rating for Soleno Therapeutics (SLNO) | Currently, the analyst consensus on Soleno Therapeutics is a Strong Buy with an average price target of $117.36. | [Link](https://longbridge.com/zh-CN/news/264449481.md) |
| A Look At Acadia Healthcare (ACHC) Valuation After David Einhorn Stake And Leadership Changes | Acadia Healthcare (ACHC) gained attention after David Einhorn disclosed a new stake, leading to increased trading volume | [Link](https://longbridge.com/zh-CN/news/275994576.md) |
| Where Were The Job Opportunities In 2025? Where Will They Be In 2026? | In 2025, job growth was minimal, with only Education and Health Care (+697,000 jobs) and Leisure and Hospitality (+119,0 | [Link](https://longbridge.com/zh-CN/news/275986113.md) |
| Jefferies Reaffirms Their Hold Rating on Novartis AG (NOVN) | Jefferies analyst James Vane has reaffirmed a Hold rating on Novartis AG (NOVN) with a price target of CHF110.00. Vane,  | [Link](https://longbridge.com/zh-CN/news/276102881.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。